Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesSleep MedicineBCBS North Dakota Phrenic Nerve Coverage | OpenPay…
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - North DakotaPolicy 212

    Phrenic Nerve Stimulation for Central Sleep Apnea

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - North Dakota Policy 212 alerts

    Get alerted when Policy 212 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Coverage of phrenic nerve stimulation for central sleep apnea; hypoglossal nerve stimulation for obstructive sleep apnea is not addressed.

    Policy Summary
    PayerBlue Cross Blue Shield - North Dakota
    PolicyPhrenic Nerve Stimulation for Central Sleep Apnea
    Policy CodePolicy 212
    Change TypeNo material change
    Effective DateOctober 1, 2026
    Last ReviewSep 1, 2026
    Next Review DateJune 1, 2027
    Key ActionDo not expect coverage for phrenic nerve stimulation for central sleep apnea because it is considered investigational.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    InvestigationalCoverage status
    Adults with moderate-severe CSA

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    FDA-approved population
    0.9%CSA prevalence
    >30Severe AHI threshold
    0Comparative RCTs

    Coverage Criteria

    Investigational Status

    The use of phrenic nerve stimulation for central sleep apnea (CSA) is considered investigational.

    Investigational Treatment

    Phrenic nerve stimulation for the treatment of central sleep apnea is considered investigational.

    ALL of the following

    • There is not enough research to determine if or how well phrenic nerve stimulation works to treat central sleep apnea.
    • More research is needed to establish the effectiveness of phrenic nerve stimulation for central sleep apnea.
    • There are no clinical practice guidelines based on high-quality research that recommend phrenic nerve stimulation for this population.

    Clinical Guideline Context

    The American Academy of Sleep Medicine's 2025 guideline on the treatment of central sleep apnea in adults suggests using transvenous phrenic nerve stimulation over no transvenous phrenic nerve stimulation in adults with central sleep apnea due to primary central sleep apnea or heart failure. This is a conditional recommendation based on very low certainty of evidence. Because transvenous phrenic nerve stimulation requires an invasive procedure, is not universally accessible, and is associated with high costs, the guideline notes that it may be more appropriate to consider other treatments first.

    Medical policies are developed to provide guidance for members and providers regarding coverage in accordance with contract terms. Benefit determinations are based in all cases on the applicable contract language. To the extent there may be any conflict between the Medical Policy and contract language, the contract language takes precedence. Contracts exclude from coverage, among other things, services or procedures that are considered investigational or cosmetic. Providers may bill members for services or procedures that are considered investigational or cosmetic. Providers are encouraged to inform members before rendering such services that the members are likely to be financially responsible for the cost of these services.

    Coding and Clinical Reference Values

    FDA Product Codemixed
    PSRFDA product code for the remedē System
    CPT CodesCPT
    33276Insertion of phrenic nerve stimulator system (pulse generator and stimulating lead[s]), including vessel catheterization, all imaging guidance, and pulse generator initial analysis with diagnostic mode activation, when performed.
    33277Insertion of phrenic nerve stimulator transvenous sensing lead (list separately in addition to code for primary procedure).
    33278Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed.
    33280Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; pulse generator only.
    33281Repositioning of phrenic nerve stimulator transvenous lead(s).
    33287Removal and replacement of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; pulse generator.
    CPT and HCPCS codesmixed
    33276Insertion of phrenic nerve stimulator system (pulse generator and stimulating lead[s]), including vessel catheterization, all imaging guidance, and pulse generator initial analysis with diagnostic mode activation, when performed.
    33277Insertion of phrenic nerve stimulator transvenous sensing lead (List separately in addition to code for primary procedure).
    33278Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed.
    33280Removal of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; pulse generator only.
    33281Repositioning of phrenic nerve stimulator transvenous lead(s).
    33287Removal and replacement of phrenic nerve stimulator, including vessel catheterization, all imaging guidance, and interrogation and programming, when performed; pulse generator.
    93150Therapy activation of implanted phrenic nerve stimulator system, including all interrogation and programming.
    93151Interrogation and programming (minimum one parameter) of implanted phrenic nerve stimulator system.
    93152Interrogation and programming of implanted phrenic nerve stimulator system during polysomnography.
    93153Interrogation without programming of implanted phrenic nerve stimulator system.
    1–10 of 12
    1/2
    FDA-Approved Patient Population
    FDA-approved deviceremedē System
    Approved populationAdults
    Approved indicationModerate to severe central sleep apnea
    Adult AHI Severity Categories
    NormalAHI <5
    Mild5<AHI<15
    Moderate

    Provider Actions and Coverage Implications

    Denial Risk

    Phrenic nerve stimulation is not covered

    Phrenic nerve stimulation for central sleep apnea is considered investigational and is not covered under this policy.

    Billing Rule

    Review contract exclusions and notify the member

    Services or procedures considered investigational or cosmetic are excluded from coverage under applicable contracts. Contract language controls when it conflicts with the medical policy.

    • Inform members before rendering the service that they are likely to be financially responsible for the cost.
    • Providers may bill members for services or procedures considered investigational or cosmetic.

    Clinical Background

    Central sleep apnea (CSA) is characterized by repetitive cessation or reduction of both airflow and ventilatory effort during sleep. It may be idiopathic or secondary to conditions such as Cheyne-Stokes breathing, heart failure, stroke, medications, or high-altitude breathing.

    Treatment generally focuses on the underlying cause and may include positive airway pressure, oxygen, or other therapies depending on the CSA subtype. The remedē System is an implantable device that stimulates a phrenic nerve to activate the diaphragm and restore a normal breathing pattern.

    Definitions and Abbreviations

    Central Sleep Apnea
    AbbreviationCSA
    Core definitionRepetitive cessation or decrease in airflow and ventilatory effort during sleep
    Breathing componentsBoth airflow and ventilatory effort are affected
    Apnea-Hypopnea Index
    DefinitionNumber of apnea and hypopnea events per hour of sleep
    NormalAHI <5
    Mild to moderate5<AHI<15 is mild; 15<AHI<30 is moderate
    Policy Summary
    PayerBlue Cross Blue Shield - North Dakota
    PolicyPhrenic Nerve Stimulation for Central Sleep Apnea
    Policy CodePolicy 212
    Change TypeNo material change
    Effective DateOctober 1, 2026
    Last ReviewSep 1, 2026
    Next Review DateJune 1, 2027
    Key ActionDo not expect coverage for phrenic nerve stimulation for central sleep apnea because it is considered investigational.
    SourceLink
    On This Page
    Coverage CriteriaCoding and Clinical Reference ValuesProvider Actions and Coverage ImplicationsClinical BackgroundDefinitions and Abbreviations
    15<AHI<30
    SevereAHI >30
    Epworth Sleepiness Scale
    Scale range0 to 24
    Assessment methodShort, self-administered questionnaire
    Excessive sleepinessScores over 10
    Denial Risk

    Expect denial risk for investigational treatment

    Requests for phrenic nerve stimulation for central sleep apnea are at risk of denial because the technology is considered investigational and the evidence is insufficient to determine its effects on health outcomes.

    Note

    No randomized comparison with standard care

    The evidence review identified no randomized controlled trials comparing phrenic nerve stimulation with current standard treatments such as positive airway pressure or respiratory stimulant medication. Evidence was also very limited in patients who had failed those treatments.

    SevereAHI >30
    Epworth Sleepiness Scale
    DefinitionShort, self-administered questionnaire assessing the likelihood of falling asleep
    Situations assessedEight different situations
    Score range and thresholdScores range from 0 to 24; scores over 10 indicate excessive sleepiness
    Central Apnea Index
    AbbreviationCAI
    DefinitionNumber of central apnea events per hour of sleep
    Measurement basisCentral apnea events measured during sleep
    Obstructive Apnea Index
    AbbreviationOAI
    DefinitionNumber of obstructive apnea events per hour of sleep
    Measurement basisObstructive apnea events measured during sleep
    AHI
    AbbreviationAHI
    Expanded termApnea-Hypopnea Index
    MeasurementApnea and hypopnea events per hour of sleep
    CAI
    AbbreviationCAI
    Expanded termCentral Apnea Index
    MeasurementCentral apnea events per hour of sleep
    ESS
    AbbreviationESS
    Expanded termEpworth Sleepiness Scale
    PurposeMeasures sleepiness using a questionnaire
    TPNS
    AbbreviationTPNS
    Expanded termTransvenous Phrenic Nerve Stimulation
    Therapy typePhrenic nerve stimulation delivered through a transvenous approach
    RCT
    AbbreviationRCT
    Expanded termRandomized Controlled Trial
    Evidence typeA controlled clinical trial with randomized assignment